October 2 - 3, 2025 | San Diego, CA
Uniting North American biopharma decision-makers to innovate at speed, equipping them with the critical intelligence & partners they require to make informed pipeline decisions in early-stage R&D
Discovery & Development US 2025
Unlocking Future Insights in Biomedicine Research & Development
NextGen Biomed connects thought leaders, researchers and experts with pharmaceutical & biotech representatives to discuss the latest innovations in biomedicine discovery & development.
There will be six dedicated programmes running across three full days, which together will explore the entire value chain involved in bringing next-generation biomedicines to market, making this a must-attend event for anyone working in biotherapeutics discovery, development & manufacturing.
Hear from past attendees of last year's Biologics 2024 conference
Explore the NextGen Biomed 2025 Programme
Explore Discovery & Development US 2025: Guiding Biopharma From Target Identification To Clinical Candidate
North America's leading event for drug discovery, preclinical development and formulation returns in October 2025, uniting experts in both small molecule and biologics drug development to deliver first-in-class drugs at pace.
Through our in-depth programme and networking opportunities, the event is designed to enable biopharma leaders to identify the most high-potential targets and technologies, develop optimised workflows, and forge the right partnerships.
Discovery US
Across 6 specialized topic tracks and 50+ presentations, our congress sheds light the early stages of drug development, and the latest innovation trending in the small molecule space. Hear how experts are utilizing the modern technologies for target identification & validation and exactly how these targets are being translated into therapies using novel biomarkers. Gain exclusive insights into the unmet need for neurodegenerative diseases & the use of organoids and iPSC models to ensure the safety & efficacy of these targeted drugs – and much more!
Our Discovery US event is built to keep you ahead of the curve and supply you with the knowledge and connections you need to reinforce your research & development. Across our 3 newly co-located events, benchmark against 1000 senior professionals from across the US Biopharma market, all working to develop life-saving medicines at speed.
Agenda at a Glance
Day 1
- Track 1 | Target Identification & Validation
- Track 2 | Medicinal & Computational Chemistry
- Track 3 | Translating Targets into Therapies
Day 2
- Track 1 | Hit Identification & Screening
- Track 2 | DMPK, Pharmacology & Safety
- Track 3 | Targeting Neuroscience
Biologics US 2025
Biologics have accelerated to the forefront of the US pharmaceutical industry in the past few years, with ever-increasing demand for these large molecule products - but as we move towards more novel targets, how can we overcome the technical & regulatory challenges that come alongside this?
Our Biologics US Congress sets out to answer this question - over 6 tracks, uncover the next generation of biologics research, from novel engineering strategies to enhance antibody function & AI-driven antibody design to optimizing ADCs and utilizing these beyond just oncology. This revamped program will be packed with interactivity, networking opportunities and exclusive talks to equip you with the knowledge and connections needed to inform your pipeline and ensure the success of your R&D.
Agenda at a Glance
Day 1
- Track 4 | Antibody Discovery & Engineering
- Track 5 | Next-Gen Biologic Targets
- Track 6 | Engineering Conjugates
Day 2
- Track 4 | Tools & Technologies For Antibody Discovery & Selection
- Track 5 | Computational Tools & AI/ML-Guided Engineering
- Track 6 | Translating ADCs to the Clinic
Formulation & Drug Delivery US 2025
Join world-leading experts in drug product development and delivery for this in-person meeting on the West Coast’s scientific hub, San Diego. You’ll learn about the latest advancements in the formulation of large and small molecule-based drugs, developments in RNA, peptide and oligonucleotide design; and explore the innovations in the delivery of complex and challenging therapeutics.
Newly co-located with our Biologics and Drug Discovery summit, bringing together over 1000 attendees representing global pharmaceutical organisations, leading biotech companies as well as internationally renowned academic organisations & research institutions.
Over 50 technical presentations and case studies focused on the critical topics in AI for automated formulations, enhanced drug delivery through vaccines, PROTAC, and exosomes, as well as an exploration of sustainable drug development.
Network across two days with leading experts and engage in our interactive panel discussions focusing on the key issues in biologics, new modalities and small molecule formulation and delivery.
Agenda at a Glance
Day One
- Track 7 | Small Molecule Formulation
- Track 8 | Large Molecule Delivery
- Track 9 | Preformulation Studies
- Track 10 | RNA Design & Delivery
Day Two
- Track 7 | Large Molecule Formulation
- Track 8 | Small Molecule Drug Delivery
- Track 9 | Process Chemistry & Pharmaceutical Materials Analysis
- Track 10 | Peptide & Oligo Design & Delivery
Networking & knowledge-sharing is at the heart of what we do. With 700 pre-arranged 1-2-1 meetings and over 12 hours of networking, don't miss the opportunity to connect with 1,000 leaders from across the R&D ecosystem
Engaging Thought Leadership
Experience over 200 presentations and interactive discussions, with best practice from industry leaders to guide your novel programmes from target ID to clinical candidate.
Global Technology Showcase
An international exhibition showcasing cutting-edge technologies and services from premier providers in the scientific field.
Networking Emphasis
Unparalleled networking opportunities, including personalised 1-2-1 meetings, vibrant drinks reception, and informal gatherings to foster meaningful connections.
Start-up Zone & Poster Presentations
Inspiring Start-Up Pitches and Academic Posters unveiling the latest breakthroughs from emerging biotechs and academic spin-outs.
leading pharma, biotech, investor & academic delegates
Explore dynamic panels, engaging roundtables, and hands-on workshops designed to drive innovation and foster collaboration, including:
Panel Discussion: What Is The Next Game Changer In Antibody Engineering?
Moderator: Karen Silence, Head Preclinical Product Development, ArgenX
Panellists include Berit Olsen Krogh, Senior Research Fellow; and Lundbeck Andrew Buchanan, Principal Scientist, AstraZeneca
Roundtable: Regulatory Insights On Bringing A Peptide To Human Trials
Moderator: Paul Reid, Co-Founder & Chief Scientific Officer, Celtic Bio
Workshop: Development Of Targeted Delivery Systems
Two Presentations, followed by a Panel Discussion on 'The Next Chapter Of Oligonucleotide Delivery'
Moderator: Steve Hood, Senior Director, Oligonucleotide ADME Strategy, GSK
Panel Discussion: Navigating The Paradigm Shift Towards Greener Approaches
Moderator: Walter Cabri, Full Professor of Organic Chemistry, University of Bologna
Panellists include Daniel Sejer Pedersen, Chemical Development Specialist CMC API Development, Novo Nordisk;
Anna Maria Papini, Full Professor & Group Leader, University of Florence;
Louis Diorazio, Senior Principal Scientist, New Modalities, AstraZeneca;
Alessandra Tolomelli, Associate Professor, University of Bologna
Presentation: How The RNA Technologies Could Help To Prevent Infectious Diseases And Could Be Applied To Various Chronic Disease Immunotherapies?
Presented by: Daniel Larocque, Innovation Lead, Innovation and Emerging Science, Sanofi
Who is Speaking at Discovery & Development US 2025?
Become a driving force in accelerating the volume of safe, effective first-in-class drugs to reach patients. Discovery & Development offers a unique platform to enhance your brand visibility and connect with thousands of biopharma decision-makers. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the innovators shaping the future of R&D today
Interested in Sponsoring NextGen Biomed?
Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients. NextGen Biomed offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.
Meet Our Esteemed Sponsors
Platinum Sponsors
Gold Sponsors
Silver Sponsors
Bronze Sponsors
Network & Programme Sponsors
Start-Ups
The 1-2-1s are the best thing about Oxford Global events, well organised and good number of relevant contacts. Good high level contacts from big companies.
Advanced Therapies Specialist Team Leader,
Genscript
Biologics 2024 has been one of the best events I have attended so far in my career.
Territorial Sales Manager UK,
ACROBiosystems Co., Ltd.
Impressed by the effort to bring people together.
Business Development Director,
Bioassay
Nice set-up, with good support for exhibitors
Director of Client Relations,
ImmunoPrecise
Are you developing a cutting-edge therapy, platform or technology? Our Start-Up Zone is designed to support emerging companies looking to increase their visibility, find potential partners or early adopters, and meet their investment goals – connecting them with our community of pharma, investors, and mid-to-large size biotechs.
Located in the Exhibition Hall, the Start-Up Zone allows therapeutic pioneers to showcase their approach, conduct invaluable 1:1 meetings and deliver a quick-fire pitch.
There are two options, based on the size of your organisation with prices starting from $1990.
For further information and to get started submit the application form below.
Criteria:
The Start-Up Zone is designed for therapeutic start-ups, academic spin-outs, and early-stage technology/service providers.
To be eligible for inclusion, you must meet the following criteria:
• 0 – 5 years operating
• 0 – 30 employees
• Pre-Series A funding
What you will receive:
- 1 full conference pass
- 10-minute pitch on the Start-Up Stage
- 1x1m space in Start-Up Zone for own partnering meetings; cocktail table provided, start-up to bring 1x pull-up banner
- Logo featured on website & event platform as a participating start-up
- Ability to arrange 1:1 meetings via the congress app
The NextGen Biomed Young Scientist Awards include the best poster presentation award and are intended to honour an outstanding individual performance for a scientific work by a PhD student, PostDoc or early career scientist.
Please submit your poster presentation by no later than 13th January 2025 in the below category:
- Protein/Antibody Engineering
- Bioanalysis & Characterisation
- Next Generation Biotherapeutics
- Peptides Chemistry & Therapeutics
- Oligonucleotides Chemistry & Therapeutics
- Sustainable Chemistry & Manufacturing
- Student (PhD), PostDoc or early career scientist under 35 years of age. Proof must be provided via an active student ID card or a copy of status
- Applicants must be the first AND presenting author of the submitted paper and register for the meeting by 13th January 2025
- ONLY ONE YSA submission per person will be accepted. If authors submit multiple abstracts for consideration for the YSA, only one abstract will be taken into consideration for the YSA
Applicants must follow the procedure as follows:
- Register and submit an abstract by 13th January 2025 using the registration link to the left on this page
- Once registered you will be provided with the online abstract submission form
- Prepare the poster or platform and present it (The poster presenter should be at the poster during all breaks.)
- The 3 winners with the highest scores will be announced at the Networking Drinks on the second day of the event
- The winners’ 10-minute oral presentations will take place during the networking drinks on day 2
The platform or poster presentation will be evaluated by senior scientists (consisting of our speaking and steering group committee for the NextGen Biomed series) on the basis of originality of the approach and quality of the work (e.g. appropriate methodology, interpretation of results, conclusiveness). All participants will receive the scoring and comments after the annual meeting via email.
The 3 winners receiving the highest scores will be announced at the Networking Drinks on the Day 2 and will be given a trophy as well as £1,000 contribution towards travel costs. Oxford Global will also provide winners with PLUS Pass – 12 months access to our content platform providing access to on-demand presentations, exclusive reports and highlights.
California
USA, 92101
By Air
From San Diego International Airport (SAN), the hotel is just 1.5 miles from the airport.
- Shuttle: Use the free Sheraton shuttle, available at Terminal 1 & Terminal 2. Look for the “Hotel Courtesy Shuttle” sign.
- If Shuttle is unavailable: Take the 992 bus from the airport to the Harbor Island Drive & Sheraton Way stop (5-minute ride). Walk 5 minutes to the hotel.
By Tram/Bus
The total journey from downtown via tram and bus should take around 20-30 minutes.
- Take the San Diego Trolley:
Use the Green Line or another line that connects to the Santa Fe Depot station.
- Transfer to Bus or Walk:
From Santa Fe Depot, take Bus 992 (Airport Route) toward the San Diego International Airport. Exit at the hotel stop near Harbor Island.
- Alternatively, walk approximately 30 minutes (1.5 miles) along Harbor Drive to the hotel.
Ensure to check the trolley and bus schedules for exact timings.
By Car
- From I-5 South: Take the I-5 S towards downtown San Diego.
- Exit 17A: Take the exit for Harbor Drive.
- Follow Harbor Drive until you reach Hotel Circle South.
- The Sheraton San Diego Hotel & Marina will be on your left.
Parking Options:
- Self-parking: Available at the hotel for a fee (approx. $35 per night).
- Valet parking: Available for a higher fee (approx. $45 per night).
Ensure to check for any changes or availability on the hotel's website.
More information on accommodation coming soon
We are closely monitoring the official guidance from health authorities, local governments, and the World Health Organization in order to support the health and well-being of our global community. The health and safety of our staff, customers and clients remains our number one priority.
As we continue to move forward with hosting our events in-person in 2025, we’ve added a series of Health & Safety guidelines and precautions in order to prepare for event safety. We carry out risk assessments for all our events to evaluate fundamental considerations and how to cover multiple risk scenarios.
Oxford Global has learned that third-party companies (recently EHotel Services, Business Travel Management/btravelmanagement and Exhibitors Hotel Reservations Services) are targeting conference attendees with a fraudulent hotel booking scheme.
Please note that none of these third-party companies are associated with Oxford Global in any way, nor have Oxford Global authorised them to use their names or trademarks on information they send out to attendees.
If you are contacted by a third-party company by phone or email using Oxford Global’s name or the name of Discovery & Development US 2025 and offering accommodation services, we urge exhibitors and attendees to proceed with extreme caution before signing anything sent by these companies or entering into any conversation or replying to any emails sent from these third-party companies.